CD40 and CD154 in cell-mediated immunity.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Annual Review of Immunology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1146/ANNUREV.IMMUNOL.16.1.111PMID 9597126
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Cd40 ligand

  1997cited by this paper
• The CD40-CD154 system in anti-infective host defense.

  1997cited by this paper
• A New Mechanism of NK Cell Cytotoxicity Activation: The CD40–CD40 Ligand Interaction

  1997cited by this paper
• IL-4 and IL-10 modulation of CD40-mediated signaling of monocyte IL-1beta synthesis and rescue from apoptosis.

  1997cited by this paper
• IFN-gamma potentiates atherosclerosis in ApoE knock-out mice.

  1997cited by this paper
• T cell signaling of macrophage function in inflammatory disease.

  1997cited by this paper
• Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches.

  1997cited by this paper
• CD40-CD40L interactions in atherosclerosis.

  1997cited by this paper
• Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis.

  1997cited by this paper
• Cytokine regulation of endothelial cell function: from molecular level to the bedside.

  1997cited by this paper
• Interleukin (IL)-6 Directs the Differentiation of IL-4–producing CD4+ T Cells

  1997cited by this paper
• Immunology of atherosclerosis: the promise of mouse models.

  1996cited by this paper
• CD40 ligand-deficient mice generate a normal primary cytotoxic T-lymphocyte response but a defective humoral response to a viral infection

  1996cited by this paper
• Requirement for CD40 Ligand in Costimulation Induction, T Cell Activation, and Experimental Allergic Encephalomyelitis

  1996cited by this paper
• Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways

  1996cited by this paper
• Inhibition of atherosclerosis in CD4 T-cell-ablated and nude (nu/nu) C57BL/6 hyperlipidemic mice.

  1996cited by this paper
• Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation

  1996cited by this paper
• CD40-CD40 ligand: a multifunctional receptor-ligand pair.

  1996cited by this paper
• The relative contribution of the CD28 and gp39 costimulatory pathways in the clonal expansion and pathogenic acquisition of self-reactive T cells

  1996cited by this paper
• CD40 ligand is required for protective cell-mediated immunity to Leishmania major.

  1996cited by this paper
• Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice.

  1996cited by this paper
• Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion

  1996cited by this paper
• Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor.

  1996cited by this paper
• CD40-CD40 ligand interactions are critical in T-B cooperation but not for other anti-viral CD4+ T cell functions

  1996cited by this paper
• High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10 [published erratum appears in J Exp Med 1996 Oct 1;184(4):following 1590]

  1996cited by this paper
• Activation and homologous desensitization of human endothelial cells by CD40 ligand, tumor necrosis factor, and interleukin 1

  1996cited by this paper
• CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response

  1996cited by this paper
• Immune regulation by CD40 and its ligand GP39.

  1996cited by this paper
• CD40 Ligand-Dependent T Cell Activation: Requirement of B7-CD28 Signaling Through CD40

  1996cited by this paper
• CD40-gp39 interactions play a critical role during allograft rejection. Suppression of allograft rejection by blockade of the CD40-gp39 pathway.

  1996cited by this paper
• Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection.

  1996cited by this paper
• Transient subversion of CD40 ligand function diminishes immune responses to adenovirus vectors in mouse liver and lung tissues

  1996cited by this paper
• Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection.

  1996cited by this paper
• The Role of CD40 Ligand in Costimulation and T‐Cell Activation

  1996cited by this paper
• Cross-linking of the CD40 ligand on human CD4+ T lymphocytes generates a costimulatory signal that up-regulates IL-4 synthesis.

  1996cited by this paper
• Pneumocystis carinii: an atypical fungal micro-organism.

  1996cited by this paper
• T cell rescue of monocytes from apoptosis: role of the CD40‐CD40L interaction and requirement for CD40‐mediated induction of protein tyrosine kinase activity

  1996cited by this paper
• Immunity to Lyme disease: protection, pathology and persistence.

  1996cited by this paper
• CD40-mediated stimulation contributes to lymphocyte proliferation, antibody production, eosinophilia, and mastocytosis during an in vivo type 2 response, but is not required for T cell IL-4 production.

  1996cited by this paper
• Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice.

  1996cited by this paper
• A central role of CD40 ligand in the regulation of CD4+ T-cell responses.

  1996cited by this paper
• Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity.

  1996cited by this paper
• Protective antibodies in murine Lyme disease arise independently of CD40 ligand.

  1996cited by this paper
• The many roles of CD40 in cell-mediated inflammatory responses.

  1996cited by this paper
• CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis.

  1996cited by this paper
• Activation of human monocytes through CD40 induces matrix metalloproteinases.

  1996cited by this paper
• ImmunoBiology: The Immune System in Health and Diseases

  1996cited by this paper
• CD40 and its ligand.

  1996cited by this paper
• In the absence of a CD40 signal, B cells are tolerogenic.

  1995cited by this paper
• Activated T cells induce interleukin‐12 production by monocytes via CD40‐CD40 ligand interaction

  1995cited by this paper
• New perspectives of CD28-B7-mediated T cell costimulation.

  1995cited by this paper
• CD40 ligand-transduced co-stimulation of T cells in the development of helper function

  1995cited by this paper
• Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes.

  1995cited by this paper
• Distinct roles for B7-1 (CD-80) and B7-2 (CD-86) in the initiation of experimental allergic encephalomyelitis.

  1995cited by this paper
• Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand.

  1995cited by this paper
• Rapid induction of a novel costimulatory activity on B cells by CD40 ligand.

  1995cited by this paper
• Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals

  1995cited by this paper
• Activated T cells enhance nitric oxide production by murine splenic macrophages through gp39 and LFA‐1

  1995cited by this paper
• Studies on the interdependence of gp39 and B7 expression and function during antigen‐specific immune responses

  1995cited by this paper
• Activated human NK cells can stimulate resting B cells to secrete immunoglobulin.

  1995cited by this paper
• Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand

  1995cited by this paper
• Functional expression of CD40 antigen on human epidermal Langerhans cells.

  1995cited by this paper
• Is atherosclerosis an immunologically mediated disease?

  1995cited by this paper
• Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE.

  1995cited by this paper
• Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis

  1995cited by this paper
• CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression.

  1995cited by this paper
• Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis.

  1995cited by this paper
• The regulation of immunity to Leishmania major.

  1995cited by this paper
• New perspectives of C1328-137-mediated T cell costimulation

  1995cited by this paper
• T-Cell Signaling of Macrophage Activation: Cell Contact-Dependent and Cytokine Signals

  1995cited by this paper
• CD40 ligand has potent antiviral activity

  1995cited by this paper
• Expression of functional CD40 by vascular endothelial cells

  1995cited by this paper
• Recombinant IL–12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung

  1995cited by this paper
• CD40 ligand is required for resolution of Pneumocystis carinii pneumonia in mice.

  1995cited by this paper
• Role of the CD40‐CD40 ligand interaction in CD4+ T cell contact‐dependent activation of monocyte interleukin‐1 synthesis

  1994cited by this paper
• Resting and anergic B cells are defective in CD28-dependent costimulation of naive CD4+ T cells

  1994cited by this paper
• Tolerance induction by soluble CTLA4 in a mouse skin transplant model.

  1994cited by this paper
• Immune-deficient mice develop typical atherosclerotic fatty streaks when fed an atherogenic diet.

  1994cited by this paper
• Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm.

  1994cited by this paper
• Signals and signs for lymphocyte responses.

  1994cited by this paper
• Molecular Pathology of X‐Linked Immunoglobulin Deficiency with Normal or Elevated IgM (HIGMX‐1)

  1994cited by this paper
• The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation.

  1994cited by this paper
• Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function

  1994cited by this paper
• Humoral immune responses in CD40 ligand-deficient mice

  1994cited by this paper
• Activation of human dendritic cells through CD40 cross-linking

  1994cited by this paper
• Mice deficient for the CD40 ligand.

  1994cited by this paper
• Transplantation tolerance induced by CTLA4-Ig.

  1994cited by this paper
• The ups and downs of T cell costimulation.

  1994cited by this paper
• Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion

  1993cited by this paper
• T cell‐mediated cognate signaling of nitric oxide production by macrophages. Requirements for macrophage activation by plasma membranes isolated from T cells

  1993cited by this paper
• Natural killer cells induce activated murine B cells to secrete Ig.

  1993cited by this paper
• Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal

  1993cited by this paper
• Induction of human IgE synthesis in B cells by mast cells and basophils

  1993cited by this paper
• CD40 ligand and its role in X-linked hyper-IgM syndrome.

  1993cited by this paper
• Macrophage activation by T cells: cognate and non-cognate signals.

  1993cited by this paper
• The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells.

  1993cited by this paper
• The regulation of T cell-dependent antibody formation in vitro by CD40 ligand and IL-2.

  1993cited by this paper
• In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39

  1993cited by this paper
• Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40.

  1993cited by this paper
• Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg.

  1992cited by this paper

• CAR-T cells co-expressing IL-7 and CCL19 promote epitope spreading to enhance antitumor immunity

  2026cites this paper
• TLR9 Inhibition Shortly After Mating Increases Fetal Resorption and Alters B- and T-Cell Costimulatory Phenotypes in an Abortion-Prone Mouse Model

  2026cites this paper
• TCR/BCR Secondary Rearrangement in Autoimmune Diseases: Molecular Mechanisms, Pathogenic Roles, and Therapeutic Frontiers

  2025cites this paper
• Immunotherapy and radiotherapy: An effective combination in cancer treatment

  2025cites this paper
• Exosomal CD40, CD25, and Serum CA19-9 as Combinatory Novel Liquid Biopsy Biomarker for the Diagnosis and Prognosis of Patients with Pancreatic Ductal Adenocarcinoma

  2025cites this paper
• CD4+ T-cell help delivery to monocyte-derived dendritic cells promotes effector differentiation of helper and cytotoxic T cells.

  2025cites this paper
• The role of soluble CD40L in autoimmune diseases

  2025cites this paper
• Sequential transcriptome profiling: comparative analysis of normal and canine lymphoma preceding detailed T-cell and B-cell subtype comparison

  2025cites this paper
• A comprehensive longitudinal analysis of the cellular immune response specific to the spike protein in healthcare workers vaccinated against SARS-CoV-2– ORCHESTRA Project

  2025cites this paper
• Tumor Microenvironment: Recent Advances in Immunotherapies of Pancreatic Cancer

  2025cites this paper
• Particular dysregulation of ‘don't eat me’ immune checkpoints in haemophagocytic lymphohistiocytosis

  2025cites this paper
• Age-Related Impairment of Innate and Adaptive Immune Responses Exacerbates Herpes Simplex Viral Infection

  2025cites this paper
• CD40 agonistic-monovalent streptavidin fusion antibody for targeted neoantigen peptide delivery and potent cancer vaccination

  2025cites this paper
• Platelets: a new therapeutic target for neurological diseases.

  2025cites this paper
• Targeting neutrophils for cancer therapy

  2025cites this paper
• PD-1 cis-targeted IL-2v in combination with radiotherapy inhibits lung cancer growth and remodels the immune microenvironment

  2025cites this paper
• Foot-and-mouth disease virus-like particle vaccine incorporating dominant T and B cell epitopes: enhanced immune response in piglets with CD154 molecules

  2025cites this paper
• Features of the subpopulation composition and functional activity of peripheral blood lymphocytes and monocytes in patients with primary autoimmune thrombocytopenia

  2025cites this paper
• Phase I(b) study evaluating the safety and efficacy of intratumoral agonistic anti-CD40 (selicrelumab) in combination with anti-PD-L1 (atezolizumab) in patients with refractory or relapsed B-cell lymphoma (ITSELF trial)

  2025cites this paper
• Evaluating the impact of using bone marrow-derived macrophages to turn early tumor sites into hot early tumor sites.

  2025cites this paper
• Tissue block-resolved developmental transcriptomic atlas of human fetal brainstem reveals gene modules with implications for neurological disorders

  2025cites this paper
• Cellular interactions in tumor microenvironment during breast cancer progression: new frontiers and implications for novel therapeutics

  2024cites this paper
• Decrease of exosomal miR-21-5p and the increase of CD62p+ exosomes are associated with the development of sepsis in polytraumatized patients.

  2024cites this paper
• Systemic Immune Response to a CD40-Agonist Antibody in Nonhuman Primates.

  2024cites this paper
• The aged microenvironment impairs BCL6 and CD40L induction in CD4 + T follicular helper cell differentiation

  2024cites this paper
• Radiotherapy Combined with Intralesional Immunostimulatory Agents for Soft Tissue Sarcomas.

  2024cites this paper
• Dendritic cell and co-stimulatory molecule targeted therapy for autoimmune diseases: a review of the newly implemented strategies

  2024cites this paper
• The multifaceted roles of cathepsins in immune and inflammatory responses: implications for cancer therapy, autoimmune diseases, and infectious diseases

  2024cites this paper
• Efficacy of IFN-γ, sCD40L, and Poly(I:C) Treated Bone Marrow-Derived Macrophages in Murine Mammary Carcinoma

  2024cites this paper
• Potential applications of mesenchymal stem cells in ocular surface immune-mediated disorders.

  2024cites this paper
• CD40L-Activated DC Promotes Th17 Differentiation and Inhibits Th2 Differentiation in Sepsis-Induced Lung Injury via cGAS-STING Signaling

  2024cites this paper
• Platelets and inter-cellular communication in immune responses: Dialogue with both professional and non-professional immune cells.

  2024cites this paper
• The engineered agonistic anti-CD40 antibody potentiates the antitumor effects of β-glucan by resetting TAMs.

  2024cites this paper
• Impact of Recombinant VSV-HIV Prime, DNA-Boost Vaccine Candidates on Immunogenicity and Viremia on SHIV-Infected Rhesus Macaques

  2024cites this paper
• Improved safety of chimeric antigen receptor T cells indirectly targeting antigens via switchable adapters

  2024cites this paper
• Serum cytokine profiles in myasthenia gravis with anti-muscle-specific kinase antibodies.

  2023cites this paper
• Same yet different — how lymph node heterogeneity affects immune responses

  2023cites this paper
• Virtual Screening of Protein Data Bank via Docking Simulation Identified the Role of Integrins in Growth Factor Signaling, the Allosteric Activation of Integrins, and P-Selectin as a New Integrin Ligand

  2023cites this paper
• A role for platelets in metabolic reprogramming of tumor-associated macrophages

  2023cites this paper
• The anti-CD40L monoclonal antibody AT-1501 promotes islet and kidney allograft survival and function in nonhuman primates

  2023cites this paper
• Single-cell transcriptome profiling of the stepwise progression of head and neck cancer

  2023cites this paper
• Rhesus macaques show increased resistance to repeated SHIV intrarectal exposure following a heterologous regimen of rVSV vector vaccine expressing HIV antigen

  2023cites this paper
• Reg family proteins contribute to inflammation and pancreatic stellate cells activation in chronic pancreatitis

  2023cites this paper
• Combinatorial immunotherapy with agonistic CD40 activates dendritic cells to express IL12 and overcomes PD-1 resistance.

  2023cites this paper
• Immune profiling in multiple sclerosis: a single-center study of 65 cytokines, chemokines, and related molecules in cerebrospinal fluid and serum

  2023cites this paper
• Identifying circulating biomarkers for major depressive disorder

  2023cites this paper
• Transcriptome-Wide Structural Equation Modeling of 13 Major Psychiatric Disorders for Cross-Disorder Risk and Drug Repurposing.

  2023cites this paper
• Immunological Processes in the Orbit and Indications for Current and Potential Drug Targets

  2023cites this paper
• Quantitative interactomic of CD40 in primary B cells

  2023cites this paper
• One Case of Ulcerative Colitis with Secondary Thrombocytosis and Literature Review

  2023cites this paper
• Sustained Intratumoral Administration of Agonist CD40 Antibody Overcomes Immunosuppressive Tumor Microenvironment in Pancreatic Cancer

  2023cites this paper
• Salivary Soluble CD40 Ligand Levels and Their Relationship to Periodontal Markers in Patients with Periodontitis and/or Obesity: An Observational Case-Control Study

  2023cites this paper
• Toll-like Receptor 9 Induced Dendritic Cell Activation Promotes Anti-Myeloperoxidase Autoimmunity and Glomerulonephritis

  2023cites this paper
• Receptor‐mediated effects of Δ9‐tetrahydrocannabinol and cannabidiol on the inflammatory response of alveolar macrophages

  2022cites this paper
• Signaling pathways, microenvironment, and targeted treatments in Langerhans cell histiocytosis

  2022cites this paper
• Bovine Immunity and Vitamin D3: An Emerging Association in Johne’s Disease

  2022cites this paper
• Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy

  2022cites this paper
• Clinical Strategies Targeting the Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma

  2022cites this paper
• Detection of rare autoreactive T cell subsets in patients with pemphigus vulgaris

  2022cites this paper
• Nanoparticle delivery of CD40 siRNA suppresses alloimmune responses by inhibiting activation and differentiation of DCs and macrophages

  2022cites this paper
• TRAF3/p38-JNK Signalling Crosstalk with Intracellular-TRAIL/Caspase-10-Induced Apoptosis Accelerates ROS-Driven Cancer Cell-Specific Death by CD40

  2022cites this paper
• T-SEM of 11 Major Psychiatric Disorders: Identification of Gene Expression Patterns for Cross-Disorder Risk and Drug Repurposing

  2022cites this paper
• Disruption of retinal inflammation and the development of diabetic retinopathy in mice by a CD40-derived peptide or mutation of CD40 in Müller cells

  2022cites this paper
• Safety and tumour-specific immunological responses of combined dendritic cell vaccination and anti-CD40 agonistic antibody treatment for patients with metastatic pancreatic cancer: protocol for a phase I, open-label, single-arm, dose-escalation study (REACtiVe-2 trial)

  2022cites this paper
• The Role of Myeloid Cells in Hepatotoxicity Related to Cancer Immunotherapy

  2022cites this paper
• Immune regulation of the ocular surface.

  2022cites this paper
• The Controversial Role of HCY and Vitamin B Deficiency in Cardiovascular Diseases

  2022cites this paper
• Genetics and epigenetics of autoimmune thyroid diseases: Translational implications.

  2022cites this paper
• Bispecific antibodies increase the therapeutic window of CD40 agonists through selective dendritic cell targeting

  2022cites this paper
• Distinct Cellular Immune Responses to SARS-CoV-2 in Pregnant Women

  2022cites this paper
• Age-Related Impairment of Innate and Adaptive Immune Responses Following Intranasal Herpes Simplex Infection

  2022cites this paper
• Thrombocytopenia in COVID-19 and vaccine-induced thrombotic thrombocytopenia

  2022cites this paper
• A Polyvalent Peptide CD40 Nanoagonist for Targeted Modulation of Dendritic Cells and Amplified Cancer Immunotherapy

  2022cites this paper
• The role of immunoglobulin E and mast cells in hypertension.

  2022cites this paper
• Platelets as Key Factors in Inflammation: Focus on CD40L/CD40

  2022cites this paper
• The Shape of Nanostructures Encodes Immunomodulation of Carbohydrate Antigen and Vaccine Development.

  2022cites this paper
• Proinflammatory oscillations over the menstrual cycle drives bystander CD4 T cell recruitment and SHIV susceptibility from vaginal challenge

  2021cites this paper
• Lung Epithelial Cells Can Produce Antibodies Participating In Adaptive Humoral Immune Responses

  2021cites this paper
• TLR9- and CD40-Targeting Vaccination Promotes Human B Cell Maturation and IgG Induction via pDC-Dependent Mechanisms in Humanized Mice

  2021influential citation
• CD40 Agonist Targeted to Fibroblast Activation Protein α Synergizes with Radiotherapy in Murine HPV-Positive Head and Neck Tumors

  2021cites this paper
• Future of immunotherapy in pancreas cancer and the trials, tribulations and successes thus far.

  2021cites this paper
• CD40 plays roles in T cell-dependent response and B cell activation and differentiation in Nile tilapia (Oreochromis niloticus)

  2021cites this paper
• Bayesian analysis of cytokines and chemokine identifies immune pathways of HBsAg loss during chronic hepatitis B treatment

  2021cites this paper
• Macrophage Plasticity and Polarization Are Altered in the Experimental Model of Multiple Sclerosis

  2021cites this paper
• Agonistic CD40 Antibodies in Cancer Treatment

  2021cites this paper
• Pancreas cancer: Therapeutic trials in metastatic disease

  2021cites this paper
• New Insights Into Novel Therapeutic Targets in ANCA-Associated Vasculitis

  2021cites this paper
• Protective effect of Polygonatum sibiricum polysaccharide on cyclophosphamide-induced immunosuppression in chickens.

  2021cites this paper
• Identification and functional characterization of CD154 in T cell-dependent immune response in Nile tilapia (Oreochromis niloticus).

  2021cites this paper
• Immunotherapy as a boon in cancer treatment

  2021cites this paper
• IL-1 and CD40/CD40L platelet complex: elements of induction of Crohn’s disease and new therapeutic targets

  2021cites this paper
• Enhanced Expression of miR-181b in B Cells of CLL Improves the Anti-Tumor Cytotoxic T Cell Response

  2021cites this paper
• Soluble CD40L activates soluble and cell-surface integrin αvβ3, α5β1, and α4β1 by binding to the allosteric ligand-binding site (site 2)

  2021cites this paper
• APX005M, a CD40 agonist antibody with unique epitope specificity and Fc receptor binding profile for optimal therapeutic application

  2021cites this paper
• A Critical Review about Different Vaccines against Classical Swine Fever Virus and Their Repercussions in Endemic Regions

  2021cites this paper
• Distinct cDC subsets co-operate in CD40 agonist response while suppressive microenvironments and lack of antigens subvert efficacy

  2021cites this paper
• Cladribine Alters Immune Cell Surface Molecules for Adhesion and Costimulation: Further Insights to the Mode of Action in Multiple Sclerosis

  2021cites this paper
• T and B cell abnormalities, pneumocystis pneumonia, and chronic lymphocytic leukemia associated with an AIOLOS defect in patients

  2021cites this paper
• Prediction and mitigation of mutation threats to COVID-19 vaccines and antibody therapies

  2021cites this paper
• [The CD40-CD40L axis: Current and future implications in clinical immunology].

  2021cites this paper